Biggest News Aggregation in the World
📰 End Depression News

End Depression News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from End Depression. Real-time updates on events, politics, business and more.

Actinogen announces first patient treated in depression and cognitive impairment Phase 2 clinical trial

Approximately 5% of Americans suffer from Major Depressive Disorder (MDD),[1]which is commonly associated with "foggy thinking" but a new clinical trial raises hope that once-a-day oral drug Xanamemmay assist where treatment by anti-depressant medication alone is inadequate SYDNEY, Dec. 14, 2022 /PRNewswire/ --Actinogen Medical Limited (ASX: ACW)is pleased to announce that the first patient has been randomized and treated in the XanaCIDD Phase 2 depression clinical trial that will meas...
New South Wales United States Steven Gourlay Actinogen Medical Limited Major Depressive Disorder Cogstate Cognitive Test Battery

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science